NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
17 hedge funds and large institutions have $1.17M invested in InVivo Therapeutics Holdings Corp in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
17
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
| 1 | +$288K | |
| 2 | +$266K | |
| 3 | +$200K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$132K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$93K |
Top Sellers
| 1 | -$143K | |
| 2 | -$123K | |
| 3 | -$52K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$40K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$40K |